94 results on '"Cognetti, David M."'
Search Results
2. Predictive capacity of immune‐related adverse events and cytokine profiling in neoadjuvant immune checkpoint inhibitor trials for head and neck squamous cell carcinoma
3. Modified Frailty Index Associates With Transoral Robotic Surgery Complications and Survival: A National Database Study
4. Proposal for standardized ultrasound analysis of the salivary glands: Part 1 submandibular gland
5. List of Contributors
6. Sialendoscopy
7. Effect of preoperative programmed death‐1 or programmed death ligand‐1 immune check point inhibition on complications after surgery for primary head and neck cancer
8. Nivolumab and ipilimumab in combination with radiotherapy in patients with high-risk locally advanced squamous cell carcinoma of the head and neck
9. Supplementary Figure from Tadalafil Enhances Immune Signatures in Response to Neoadjuvant Nivolumab in Resectable Head and Neck Squamous Cell Carcinoma
10. Supplementary Figure from Tadalafil Enhances Immune Signatures in Response to Neoadjuvant Nivolumab in Resectable Head and Neck Squamous Cell Carcinoma
11. Supplementary Figure from Tadalafil Enhances Immune Signatures in Response to Neoadjuvant Nivolumab in Resectable Head and Neck Squamous Cell Carcinoma
12. Feasibility and Cost of Telehealth Head and Neck Cancer Survivorship Care: A Systematic Review
13. Evaluating YouTube videos on sialendoscopy as an educational resource for patients
14. Pearls, Perils, and Learning Curve of Salivary Endoscopy
15. Effects of Prior Tracheostomy on Total Laryngectomy Outcomes
16. Patient experiences of sialendoscopy with monitored anesthesia care versus general anesthesia
17. An Updated Patient‐Centered Sialadenitis Instrument: The Obstructive Salivary Problem Impact Test (SPIT)
18. Analysis of cost and outcomes in bony versus soft tissue midface free flap reconstruction
19. A phase 1, first-in-human, drug dose-escalation study of RM-1995 photoimmunotherapy, as monotherapy or combined with pembrolizumab, in patients with advanced cutaneous squamous cell carcinoma or with head and neck squamous cell carcinoma.
20. Risk factors for gastrostomy tube dependence in transoral robotic surgery patients
21. Otolaryngology Subspecialty Surgical Rescheduling Rates During the COVID-19 Pandemic
22. Tadalafil Enhances Immune Signatures in Response to Neoadjuvant Nivolumab in Resectable Head and Neck Squamous Cell Carcinoma
23. Phase 1/2a, open‐label, multicenter study ofRM‐1929 photoimmunotherapy in patients with locoregional, recurrent head and neck squamous cell carcinoma
24. Pathologic and radiographic responses in a window of opportunity for durvalumab plus metformin trial for squamous cell carcinoma of the head and neck (HNSCC).
25. Oncologic outcomes of human papillomavirus–associated oropharynx carcinoma treated with surgery alone: A 12‐institution study of 344 patients
26. Improved efficiency of sialendoscopy procedures at an ambulatory surgery center
27. Adjuvant Cesium‐131 Brachytherapy for Patients Intolerant of External Beam Radiation Therapy
28. Functional Swallow-Related Outcomes Following Transoral Robotic Surgery for Base of Tongue Carcinoma
29. Comparison of general anesthesia and monitored anesthesia care for sialendoscopy procedures
30. Discordant Responses Between Primary Head and Neck Tumors and Nodal Metastases Treated With Neoadjuvant Nivolumab: Correlation of Radiographic and Pathologic Treatment Effect
31. Tracheostomy During the COVID-19 Pandemic: Comparison of International Perioperative Care Protocols and Practices in 26 Countries
32. Comment on “Tracheostomy in COVID‐19 Patients: Why Delay or Avoid?”
33. The underappreciated role of auriculotemporal nerve involvement in local failure following parotidectomy for cancer
34. COVID ‐19 pandemic and health care disparities in head and neck cancer: Scanning the horizon
35. Neoadjuvant nivolumab (N) plus weekly carboplatin (C) and paclitaxel (P) in resectable locally advanced head and neck cancer.
36. Nivolumab (Nivo) and ipilimumab (Ipi) in combination with radiotherapy (RT) in high-risk patients (pts) with locally advanced squamous cell carcinoma of the head and neck (LA SCCHN).
37. Window-of-opportunity trial of nivolumab with or without the IDO inhibitor BMS-986205 in patients with resectable squamous cell carcinoma of the head and neck (SCCHN).
38. Salivary gland disease in the era of COVID ‐19 pandemic
39. Tracheostomy Management during the COVID‐19 Pandemic
40. Evaluating the impact of smoking on disease‐specific survival outcomes in patients with human papillomavirus–associated oropharyngeal cancer treated with transoral robotic surgery
41. Survivorship support in head and neck cancer: American Head and Neck Society survey
42. Predictors of Mortality in HPV‐Associated Oropharynx Carcinoma Treated With Surgery Alone
43. Risk factors for unplanned readmission in total laryngectomy patients
44. Safety of nivolumab and ipilimumab in combination with radiotherapy in patients with locally advanced squamous cell carcinoma of the head and neck (LA SCCHN).
45. Discordant treatment response in primary tumors and lymph node metastases after four weeks of preoperative PD-1 blockade in head and neck squamous cell carcinoma (HNSCC).
46. Results of a phase 2a, multicenter, open-label, study of RM-1929 photoimmunotherapy (PIT) in patients with locoregional, recurrent head and neck squamous cell carcinoma (rHNSCC).
47. A global phase III multicenter, randomized, double-arm, open label trial of ASP-1929 photoimmunotherapy versus physician’s choice standard of care for the treatment of patients with locoregional, recurrent head and neck squamous cell carcinoma (rHNSCC).
48. Response to “Letter to the Editor”: Eagle’s Syndrome Requires Further Consideration
49. Assessment of quality and consistency of monoclonal antibodies for CB1 and CB2 in head and neck squamous cell carcinoma
50. Sensitivity of Fine-Needle Aspiration and Imaging Modalities in the Diagnosis of Low-Grade Mucoepidermoid Carcinoma of the Parotid Gland
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.